Investor Presentaiton
ONE OF THE MOST WELL CAPITALIZED AND
FINANCIALLY STABLE U.S. CANNABIS COMPANIES
• Executed a non-dilutive $300M debt raise in
January of 2020, raising net proceeds of $185.7M (1)
.
This provides Curaleaf with one of the strongest
balance sheets in the sector, with $176.4M of cash
on hand as of 3/31/20
•
4 consecutive quarters of positive AEBITDA, with
$20M of AEBITDA in 1Q20, representing 77% of
FY2019 AEBITDA
• Continued support from key shareholders:
.
As a group, committed to providing $100M in
additional capital if needed for opportunistic
acquisitions
Despite the onset of the COVID-19 pandemic,
managed revenue grew 29% sequentially and
AEBITDA grew 45% sequentially in 1Q20
Ample cash on hand to fund our current business for
future growth and announced acquisitions
• Several states continue to generate operating cash
flow, paving the way for significant organic cash flow
(1) Net proceeds are after the retirement of prior senior-debt obligations and other fees associated with the debt raise.
curaileaf.
17View entire presentation